Device Leads

Attain Command + Surevalve

Payments companies reported to CMS as associated with Attain Command + Surevalve. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$54Kassociated payments (2023-2025)
553clinicians with associated payments
1company reporting

By year

2023 $23K
2024 $19K
2025 $11K

Payments reported as associated with Attain Command + Surevalve, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $34K
Cardiovascular Disease $10K
Interventional Cardiology $2,688
Family $1,358
Physician Assistant $1,166
Internal Medicine $806

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Attain Command + Surevalve

These are the largest totals companies reported as associated with Attain Command + Surevalve. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael West Farmington, NM Clinical Cardiac Electrophysiology $15,000.00
Jeff Hsing Corvallis, OR Clinical Cardiac Electrophysiology $1,636.37
Ryan Aleong Aurora, CO Clinical Cardiac Electrophysiology $1,396.56
William Espar Michigan City, IN Cardiovascular Disease $1,324.64
Jeremiah Wasserlauf Skokie, IL Clinical Cardiac Electrophysiology $728.65
Hiro Kawata Springfield, OR Clinical Cardiac Electrophysiology $657.40
Alexander Ivanov Bridgewater, NJ Clinical Cardiac Electrophysiology $612.39
Nicolas Karam Plattsburgh, NY Clinical Cardiac Electrophysiology $556.52
Babak Bozorgnia Allentown, PA Clinical Cardiac Electrophysiology $527.60
Colin Burnett Milwaukee, WI Cardiovascular Disease $426.96

Prescribed Attain Command + Surevalve?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.